Retrobulbar optic neuritis associated with infliximab.
Foroozan
Rod
R
Neuro-Ophthalmology Service, Wills Eye Hospital, 900 Walnut St, Philadelphia, PA 19107, USA.
Buono
Lawrence M
LM
Sergott
Robert C
RC
Savino
Peter J
PJ
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D000069285:Infliximab; D008279:Magnetic Resonance Imaging; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D009902:Optic Neuritis / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D009916:Orbital Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism; D014786:Vision Disorders / Q000139:chemically induced / Q000175:diagnosis / Q000188:drug therapy; D014792:Visual Acuity; D058609:Visual Field Tests; D014794:Visual Fields
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D005938:Glucocorticoids; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D008775:Methylprednisolone